Abdominal Imaging Division, Department of Radiology, University of Washington Medical Center, Seattle, WA, USA.
Abdominal Imaging Division, Department of Radiology, University of Texas, Southwestern Medical Center, Dallas, TX, USA.
Abdom Radiol (NY). 2020 Apr;45(4):1050-1056. doi: 10.1007/s00261-020-02436-3.
To assess the frequency and indications for use of oral water-soluble contrast challenge as a diagnostic test for small bowel obstruction in four regions of the USA.
We distributed a 9-question web-based survey to the abdominal section heads of academic radiology departments throughout the USA (N = 97). The questions pertained to use of water-soluble contrast for management of small bowel obstruction. Descriptive statistics and Fisher's exact tests were used for data analysis.
The overall response rate was 46%. Eighty percent of the responding hospitals had more than 500 beds in operation. Water-soluble contrast challenge was considered standard of care for management of non-operative small bowel obstruction in 60% of the responding radiology departments. The majority of the responding departments (41%) performed 2-8 contrast challenge studies per month on average. The most frequent indication for the study was distinguishing partial vs complete bowel obstruction. Eighty percent of the responding radiologists believed that the contrast challenge is useful for management of small bowel obstruction. Overall, there was no statistically significant difference in frequency and indication for use of water-soluble contrast challenge based on geographic location.
The water-soluble contrast challenge was considered standard of care for non-operative management of small bowel obstruction in majority of the academic radiology departments represented in this survey. Surgeons were referring clinicians in every case. The most common clinical indication for the study was distinguishing partial versus complete small bowel obstruction.
评估美国四个地区将口服水溶性对比剂挑战作为诊断小肠梗阻的检查手段的使用频率和适应证。
我们向美国学术放射科系的腹部科主任发放了一份 9 个问题的网络调查(N=97)。问题涉及水溶性对比剂在小肠梗阻管理中的应用。使用描述性统计和 Fisher 确切检验进行数据分析。
总体应答率为 46%。80%的应答医院运营中的床位超过 500 张。60%的应答放射科认为水溶性对比剂挑战是治疗非手术性小肠梗阻的标准治疗方法。大多数应答科室(41%)平均每月进行 2-8 次对比剂挑战研究。该研究最常见的适应证是区分部分性与完全性肠梗阻。80%的应答放射科医生认为对比剂挑战对小肠梗阻的治疗有用。总体而言,根据地理位置,水溶性对比剂挑战的使用频率和适应证无统计学差异。
在这项调查中,大多数参与的学术放射科都将水溶性对比剂挑战视为非手术治疗小肠梗阻的标准治疗方法。在每种情况下,外科医生都是转诊的临床医生。该研究最常见的临床适应证是区分部分性与完全性小肠梗阻。